Clinical significance of myocardial magnetic resonance abnormalities in patients with sarcoidosis: A 1-year follow-up study

Chest

Volumn 122, Issue 6, 2002, Pages 1895-1901

  Vignaux, Olivier ^a   Dhote, Robin ^a   Duboc, Denis ^a   Blanche, Philippe ^a   Dusser, Daniel ^a   Weber, Simon ^a   Legmann, Paul ^a  

^a UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

Heart, diseases; Heart, MRI; Sarcoidosis

Indexed keywords

ADULT; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; FOLLOW UP; HISTOLOGY; HUMAN; MALE; MEDICAL ASSESSMENT; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; SARCOIDOSIS;

EID: 0036929336     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.122.6.1895     Document Type: Article

References (18)

1. Mayock RL, Bertrand P, Morrison CE. Manifestations of sarcoidosis. Am J Med 1963; 35:67-89
2. Silverman KJ, Hutchins GM, Bulkley BH. Cardiac sarcoid: A clinicopathologic study of 84 unselected patients with systemic sarcoidosis. Circulation 1978; 58:1204-1211
3. Roberts WC, McAllister HA, Ferrans VJ. Sarcoidosis of the heart. Am J Med 1977; 63:86-108
4. Valantine H, McKenna WJ, Nihoyannopoulos P. Sarcoidosis: A pattern of clinical and morphological presentation. Br Heart J 1987; 57:256-263
5. Abeler V. Sarcoidosis of the cardiac conducting system. Am Heart J 1979; 97:701-707
6. Sharma OP. Cardiac and neurologic dysfunction in sarcoidosis. Clin Chest Med 1997; 18:813-825
7. Riedy K, Fisher MR, Belic N, et al. MR imaging of myocardial sarcoidosis. AJR Am J Roentgenol 1988; 151:915-916
8. Dupuis JM, Victor J, Furber A, et al. Value of magnetic resonance imaging in sarcoidosis: A propos of a case. Arch Mal Cœur Vaiss 1994; 87:105-110
9. Chandra M, Silverman ME, Oshinski J, et al. Diagnosis of cardiac sarcoidosis aided by MRI. Chest 1996; 110:562-565
10. Matsuki M, Matsuo M. MR findings of myocardial sarcoidosis. Clin Radiol 2000; 55:323-325
11. Inoue S, Shimada T, Murakami Y. Clinical significance of gadolinium-DTPA-enhanced MRI for detection of myocardial lesions in a patient with sarcoidosis. Clin Radiol 1999; 54:70-72
12. Schulz-Menger J, Strohm O, Dietz R, et al. Visualization of cardiac involvement in patients with systemic sarcoidosis applying contrast-enhanced magnetic resonance imaging. MAGMA 2000; 11:82-83
13. Shimata T, Shimada K, Sakane T, et al. Diagnosis of cardiac sarcoidosis and evaluation of the effects of steroid therapy by gadolinium-DTPA-enhanced magnetic resonance imaging. Am J Med 2001; 110:520-527
14. Vignaux O, Augui J, Coste J, et al. Comparison of optimized single-shot fast spin-echo with conventional spin-echo sequences for MR imaging of the heart: Initial experience. Radiology 2001; 219:545-550
15. Matsumori A, Hara M, Nagai S, et al. Hypertrophic cardiomyopathy as a manifestation of cardiac sarcoidosis. Jpn Circ J 2000; 64:679-683
16. Yasaki Y, Isobe M, Hiroe M, et al. Prognostic determinants of long-term survival in Japanese patients with cardiac sarcoidosis treated with prednisone. Am J Cardiol 2001; 88:1006-1010
17. Aso H, Takeda K, Ito T, et al. Assessment of myocardial fibrosis in cardiomyopathic hamsters with gadolinium-DTPA enhanced magnetic resonance imaging. Invest Radiol 1998; 33:22-32
18. Uemura A, Morimoto S, Hiramitsu S, et al. Histologic diagnostic rate of cardiac sarcoidosis: Evaluation of endomyocardial biopsies. Am Heart J 1999; 138:299 -302